GovChime
Notice ID: 31693bf1d11a4019a9bef96e8d6d615bSpecial Notice

RADIOPHARMACEUTICALS (LUTATHERA and PLUVICTO)

Archived on September 4, 2024. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
12:00 PM UTC−05:00
Posted
August 15, 2024
Notice type
Special Notice
Agency
Department of WarDepartment of the Army

Notice details

Office
W40M MRC0 WEST
Place of performance
JBSA Ft Sam Houston, 78234
Last updated
Sep 25, 2026

Identifiers

Solicitation number
W81K0024R0020
Notice ID
31693bf1d11a4019a9bef96e8d6d615b

Description

Notice of Intent for Solicitation: W81K0024R0020 The Medical Readiness Contracting Office-West intends to award a sole source contract to Advanced Accelerator Applications USA (AAA), for 2 FDA approved radiopharmaceuticals of which they are the manufacturer. The Department of Nuclear Medicine Service at Brooke Army Medical Center (BAMC) requires two Food and Drug Administration (FDA) approved products that are required for the imaging and treatment of somatostatin receptor-positive gastroeteropancreatic neuroendocrine tumors and for the treatment of adult patients with prostatic-specific membrane antigen-positive metastatic castration-resistant prostate cancer. NAICS: 325412 Pharmaceutical Preparation Manufacturing; Size Standard 1,300. The following are description of items and quantities: Lutetium Lu-177 Dotatate (Lutathera) Lutetium Lu-177 Vipivotide Tetraxetan (Pluvicto) Ordering Period LUTATHERA qty PLUVICTO qty Ordering Period 1: 1 October 2024 - 30 September 2025 31 108 Ordering Period 2: 1 October 2025 - 30 September 2026 30 108 Ordering Period 3: 1 October 2026 - 30 September 2027 30 120 Ordering Period 4: 1 October 2027 - 30 September 2028 30 120 Ordering Period 5: 1 October 2028 - 30 September 2029 30 140 This notice of intent is not a request for quotations and a solicitation will not be issued in conjunction with the notice of intent. Any vendor that believes it can provide the stated supplies may provide a capability statement. Verbal responses are not acceptable and will not be considered.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Contracting Officer

Primary Contact

Secondary Contact

Documents

No documents available.

Lifecycle

Solicitation:W81K0024R0020
  1. Special NoticeCurrentAug 15, 2024

    RADIOPHARMACEUTICALS (LUTATHERA and PLUVICTO)

    Notice 31693bf1d11a4019a9bef96e8d6d615b on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

W81K0024R0020

Archive Date

Sep 4, 2024

Office Address

JBSA FT SAM HOUSTON, TX, 78234-4504